Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Nicotinic acetylcholine receptor ligands for nicotine addiction and CNS disorders

Nov. 11, 1998

Apotex conducting early studies on oral chelating agents

Oct. 27, 1998

Animal studies provide further support for the role of dopaminergic systems in alcoholism

Oct. 26, 1998

Novel orally active iron chelator presented by Novartis researchers

Oct. 21, 1998

Nicotinic acetylcholine receptor ligands from Pfizer for addictive and CNS disorders

Oct. 13, 1998

SmithKline Beecham to market smoking cessation patch in China

Oct. 6, 1998

SmithKline Beecham acquires transdermal nicotine product in Australia and New Zealand

Oct. 5, 1998

Caroverine shown to effective treatment for alcohol withdrawal syndrome

Sep. 22, 1998

Nicotine Inhaler launched nationwide in the U.S.

Sep. 11, 1998

Tropane analogues claimed for cocaine addiction by HHS

Sep. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...